| Literature DB >> 9761094 |
E Garbarz1, B Farah, A Vuillemenot, F André, M Angioï, J Machecourt, J P Bassand, J E Wolf, N Danchin, B Prendergast, B Iung, A Vahanian.
Abstract
We studied the in-hospital outcome of 138 consecutive patients who received abciximab as a "rescue" intervention for complicated coronary angioplasty in a high-risk clinical setting. "Rescue" treatment with abciximab was associated with clinical and angiographic success rates of 83% and 84%, respectively, whereas the risk of bleeding was higher in patients of low body weight.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9761094 DOI： 10.1016/s0002-9149(98)00459-7
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778